Industry News

      Domain Therapeutics Appoints Sean A. MacDonald as Chief Executive Officer

      STRASBOURG, France & MONTREAL & BOSTON--(BUSINESS WIRE)--Domain Therapeutics a global clinical-stage biopharmaceutical company developing innovative drug candidates in immuno-oncology targeting G...

      Pint Pharma Announces the Approval of ORLADEYO® (berotralstat), the First Oral Therapy Indicated for Preventing Hereditary Angioedema (HAE) Attacks in Adult and Pediatric Patients...

      SÃO PAULO--(BUSINESS WIRE)--It is with great pleasure that we announce the approval by the Brazilian Health Regulatory Agency (ANVISA) of the...

      Genentech’s Subcutaneous Ocrevus One-Year Data Demonstrates Near-Complete Suppression of Clinical Relapses and Brain Lesions in Patients With Progressive and Relapsing Forms of MS

      SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today data from the...

      Future Pak Confirms Proposal to Acquire Vanda Pharmaceuticals for $7.25 to $7.75 Per Share in Cash

      WIXOM, Mich.--(BUSINESS WIRE)--Future Pak LLC (“Future Pak”) today announced that it has submitted three proposals since February to acquire all of...

      Sage Therapeutics Announces Topline Results from Phase 2 PRECEDENT Study of Dalzanemdor (SAGE-718) in the Treatment of Mild Cognitive Impairment in Parkinson’s Disease

      CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics, Inc. (Nasdaq: SAGE) announced today topline results from PRECEDENT, a double-blind, placebo-controlled Phase 2 study of the...

      Research on Plant-Based SARS-CoV-2 Vaccine to Be Presented at One Health Symposium by PlantPharm BioMed

      MILWAUKEE--(BUSINESS WIRE)--Dr. Richard Matner, President of PlantPharm BioMed, Ltd. will be presenting at the International Symposium on One Health Research: Improving...

      Recent Articles